Change in Metabolic Syndrome Parameters With Antipsychotic Treatment in the CATIE Schizophrenia Trial: Prospective Data From Phase 1

BACKGROUND: The metabolic syndrome (MS) is associated with increased risk for diabetes mellitus and coronary heart disease, and is highly prevalent among schizophrenia patients. Given concerns over antipsychotic metabolic effects, this analysis explored MS status and outcomes in phase 1 of the CATIE...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Meyer, Jonathan M., Davis, Vicki G., Goff, Donald C., McEvoy, Joseph P., Nasrallah, Henry A., Davis, Sonia M., Rosenheck, Robert A., Daumit, Gail L., Hsiao, John, Swartz, Marvin S., Stroup, T. Scott, Lieberman, Jeffrey A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3673564/
https://ncbi.nlm.nih.gov/pubmed/18258416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.schres.2007.12.487
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados